List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
BR.21A Randomized Placebo-Controlled Study of OSI-774 (Tarceva™) in Patients With Incurable Stage IIIB/IV Non-Small Cell Lung Cancer Who Have Failed Standard Therapy For Advanced or Metastatic Disease English


English


OSI-774-104An Open-Label Study to Characterize the Pharmacokinetic Parameters of Erlotinib (Tarceva®, OSI-774) in Cancer Patients with Advanced Solid Tumors with Adequate and Moderately Impaired Hepatic Function English


English


OSI-774-107A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva® (erlotinib) in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens English


English


OSI-774-108A Phase 1b Study of Erlotinib in Combination with Gemcitabine and nab-Paclitaxel in Patients with Previously Untreated Advanced Pancreatic Cancer English


English


NextLast

QUICK SEARCH

USEFUL LINKS